الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 136 |  |  |
| | | from | 136 | | |
Abstract
Migraine is the 2nd commonest painful and debilitating disease worldwide. It affects about 15% of females and 6% of males over one year period. It has a worldwide prevalence of about one in 7 persons. According to the Global Burden of Disease Study, it ranks as the 7th most common cause of disability globally, rising to the commonest cause in those below 50 years of age. The latest version of the ICHD – III (beta) classifies migraine as (i) migraine with no aura, (ii) migraine with aura, (iii) CM, (iv) complications of migraine, (v) probable migraine, and (vi) episodic syndrome which might be accompanied by migraine. There are many diseases that are frequently comorbid with migraine. These include anxiety, chronic pain, fibromyalgia, bipolar disorder, cardiovascular disease, epilepsy, hypertension, headache (other than migraine), irritable bowel syndrome, sleep disorders, obesity, and gastroesophageal reflux disorder Understanding comorbid conditions in migraine patients are significant. Their determination helps identify common or shared underlying genetic and biological mechanisms of disease. This facilitates the development of novel therapies targeted (Lipton et al, 2019). The aim of the study was to better understand the distribution and burden of migraine between our outpatient attendants and help identify the groups at highest risk for developing Migraine. Moreover, the study assessed the association between sociodemographics of patients with migraine with their different comorbidities to identify the most significant factors that affect the comorbidity profile.